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Muscle ﬁbers are formed during embryonic development by the fusion of mononucleated myoblasts. The
spatial structure and molecular composition of the sarcolemma are crucial for the myoblast recognition
and fusion steps. Cyclodextrins are a group of substances that have the ability to solubilize lipids through
the formation of molecular inclusion complexes. Previously, we have shown that methyl-b-cyclodextrin
(MbCD) enhances muscle differentiation. Here, we analyzed the effects of a-cyclodextrin (aCD) during
myogenesis. Myogenic cultures treated with aCD showed an increase in myoblast fusion and in the
expression of myogenin, sarcomeric tropomyosin and desmin. aCD-conditioned media accelerates myo-
genesis in a similar way as aCD does, and increased levels of IL-4 were found in aCD-conditioned media.
aCD-induced effects on myogenesis were inhibited by an anti-IL4 antibody. These results show that
a-cyclodextrin induces myogenic differentiation by the release of IL-4.
 2011 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
The formation of a skeletal muscle ﬁber begins with the with-
drawal of committedmononucleated precursors from the cell cycle.
Thesemyoblasts elongate while aligningwith each other, guided by
recognition between their membranes. This step is followed by cell
adhesion, fusion and the formation of long and striated multinucle-
ated myotubes. In particular, when myoblasts withdraw from the
mitotic cycle, signiﬁcant modiﬁcations take place in a number of
biochemical and biophysical properties of the plasma membrane,
including cell surface proteins, phospholipid distribution across
the bilayer, membrane ﬂuidity and remodeling [1]. Many plasma
membrane proteins, as well as many soluble proteins, have been
implicated in myoblast adhesion and fusion [2–5]. Although cell
surface proteins are indispensable to these processes, plasmamem-
brane lipids are also involved. It has been shown that phosphatidyl-
serine is transiently exposed at the sites of cell–cell contact and is
functionally required for myotube formation [6]. Furthermore,
addition of puriﬁed phospholipase C to the culture medium com-
pletely inhibits myoblast fusion in a reversible manner without
affecting cell proliferation [7]. Membrane cholesterol has also been
implicated in myoblast fusion. The addition of cholesterol to theein).
sevier OA license.medium 4 h before fusion onset inhibits fusion [8]. It has been
shown that a decrease in membrane cholesterol is necessary for
myoblast fusion [9–11]. Using ﬁlipin and freeze-fracture electron
microscopy, Sekiya and collaborator showed that the early stages
of fusion were characterized by the depletion of cholesterol from
the membrane apposition sites, at which the plasma membranes
of two adjacent cells were in close contact. Membrane fusion took
place at several points within the ﬁlipin–cholesterol complex-free
areas.
Although several papers are dedicated to study the involvement
of membrane lipids during myoblast fusion, a full comprehension
of this complex molecular and cellular phenomenon is still incom-
plete. One simple approach to study the role of membrane lipids
during muscle differentiation is to selectively deplete membrane
lipids from myogenic cells. The most common means of modifying
the lipid content of cell membranes is the incubation of cells with
cyclodextrins (CDs), a family of compounds, which, due to the
presence of a relatively hydrophobic cavity, can be used to extract
lipids from cell membranes. Different cyclodextrins have different
potencies for solubilizing phospholipids and cholesterol: b-
cyclodextrins (bCDs) are the most efﬁcient in extracting choles-
terol from membranes, while a-cyclodextrins (aCDs), on the other
hand, are the most efﬁcient in extracting phospholipids [12]. These
differences have been attributed to the size and hydrophobicity of
the CD inner cavities [13]. A methylated form of bCD, the methyl-
b-cyclodextrin (MbCD), was found to be even more efﬁcient than
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ing the investigation of cellular and molecular mechanisms associ-
ated with cholesterol depletion. Our group has shown that
cholesterol depletion by MbCD induces the differentiation of
chick-cultured myogenic cells [14] by the activation of the Wnt/
b-catenin signaling pathway [15,16].
aCD has been widely used in the literature as an inactive analog
control drug for MbCD treatment, since it is structurally similar to
MbCD but does not extract cholesterol from cell membranes. The
main interest of the present work was to study the effects of aCD
during myogenesis. Surprisingly, our data shows that primary cul-
tures of chick myogenic cells treated with aCD showed an increase
in myoblast fusion, in myotube thickness, and in the expression of
myogenin, tropomyosin and desmin, and therefore is not a suitable
control for MbCD treatment in myogenic cells.2. Materials and methods
2.1. Antibodies and ﬂuorescent probes
DNA-binding probe 4,6-diamidino-2-phenylindole dyhydro-
chloride (DAPI), Alexa Fluor 488- and Alexa Fluor 546-conjugated
goat anti-rabbit and goat anti-mouse immunoglobulin G antibod-
ies were purchased from Molecular Probes (Eugene, OR, USA).
The following antibodies were purchased from Sigma–Aldrich
Corp. (St. Louis, MO, USA): rabbit polyclonal anti-desmin, mouse
monoclonal anti-a-tubulin (clone DM 1A), mouse monoclonal
anti-sarcomeric tropomyosin (clone CH1) and mouse monoclonal
anti-sarcomeric a-actinin (clone EA-53). Mouse monoclonal anti-
myogenin antibody (clone F5D) from Developmental Studies
Hybridoma Bank (DSHB, University of Iowa, USA) was used.
Peroxidase-conjugated goat anti-rabbit and goat anti-mouse
antibodies were purchased from Amersham (USA).2.2. Primary myogenic cell cultures
All cell culture reagents were purchased from Invitrogen (São
Paulo, Brazil). Primary cultures of myogenic cells were prepared
from breast muscles of 11-day-old chick embryos [14]. Cells were
plated at an initial density of 7.5  105 cells/35 mm culture dishes
onto 22 mm-aclar plastic coverslips (Pro-Plastics Inc., USA) previ-
ously coatedwith rat tail collagen. Cells were grown in 2 ml of med-
ium (minimum essential medium with the addition of 10% horse
serum, 0.5% chick embryo extract, 1% L-glutamine and 1% penicil-
lin–streptomycin) under humidiﬁed 5% CO2 atmosphere at 37 C.
Twenty-four-hour cultures were treated for 30 min with either
a-cyclodextrin (aCD; Sigma–Aldrich) or methyl-b-cyclodextrin
(MbCD; Sigma–Aldrich), both at a ﬁnal concentration of 2 mM. The
2 mMﬁnal concentration of both aCD andMbCDwas chosen for cell
culture treatments because our group has previously shown that
2 mMofMbCD is sufﬁcient to induce skeletal and cardiacmuscle cell
differentiation without interfering with cell viability [14–17]. After
treatment, cultures were washed with fresh cultured medium and
grown for the next 3, 24 or 48 h.
Phase contrast images of 72 h-myogenic cultures were acquired
and the regions containing the larger diameter of each myotube
were measured using the public domain software ImageJ (http://
rsb.info.nih.gov/ij/). Fifty microscopic ﬁelds for each culture condi-
tion were used from at least three independent experiments.
Some myogenic cultures (with 24 h) were grown in the pres-
ence of one of the following conditioned media: collected from a
3 h untreated culture, collected from a 24 h untreated culture, col-
lected after 3 h of aCD treatment, collected after 24 h of aCD treat-
ment, collected after 3 h of MbCD treatment, or collected after 24 h
of MbCD treatment.Other myogenic cultures (with 24 h) were treated with aCD
(2 mM) for 30 min and then grown in the presence of either a
mouse monoclonal antibody against IL-4 (ﬁnal concentration of
10 lg/ml, R&D Systems, USA) or a recombinant IL-4 molecule (ﬁnal
concentration of 10 gg/ml, R&D Systems, USA) for the next 24 h.
2.3. Lipid extraction and cholesterol determination
Total lipids were extracted from the following conditions of the
liquid culture media: minimum essential medium (MEM), growth
medium stock solution (GM; prior to cell feeding), growth medium
from untreated cell cultures (Ct), growth medium collected imme-
diately after aCD treatment, and growth medium collected imme-
diately after MbCD treatment. Brieﬂy, myogenic cells were washed
with cold phosphate buffered saline (PBS) prior to cell detachment
and disruption in 4 ml of the extraction solution (chloro-
form:methanol:HCl, 2:1:0.075, v/v), as previously described [18].
The addition of 0.5 ml of 0.6 N HCl, followed by intense agitation
and centrifugation (10 min, 300 g) allowed us to isolate the organic
phase (containing the lipids). The ﬁnal organic phase from each
sample was dried under N2 gas and quantiﬁed gravimetrically.
Cholesterol was determined according to the method described
by Courchaine and co-workers [19]. Brieﬂy, the dried lipids from
each sample in duplicate were solubilized in 750 ll of acetic acid,
followed by the addition of 500 ll of a color reagent (0.05 g FeCl3,
2 ml H3PO4, 23 ml H2SO4), vigorously homogenized in a vortex
mixer, and kept for 10 min at room temperature. The absorbance
of each sample was determined in a U-2001 Hitachi spectropho-
tometer at 550 nm. Cholesterol (Sigma–Aldrich) was used as the
standard. The results are expressed as mg of cholesterol per ml
of sample. Aliquots (10 ll) from each sample were used for protein
determination by the phenol folin reagent, using bovine serum
albumin as the standard [20].
2.4. Lipid separation by thin layer chromatography (TLC)
The lipids dried under N2, were reconstituted in 90 ll of
chloroform:methanol:water (7.5:2.5:0.2 v/v), and spotted onto
heated-activated silica-gel 60 TLC plates. The plateswere developed
in chloroform:acetone:methanol:acetic acid:water (120:45:39:
36:24, v/v), and the lipids developed by the exposure of the TLC
plates to iodine vapors. The identiﬁcation of each speciﬁc phospho-
lipidwas obtained by comparison of the relativemobility (Rf values)
of commercial standards in the same solvent system.
2.5. Immunoﬂuorescence microscopy and digital image acquisition
Myogenic cells were rinsed with PBS and ﬁxed with 4% parafor-
maldehyde in PBS for 10 min at room temperature. They were then
permeabilized with 0.5% Triton-X 100 in PBS for 30 min. The same
solution was used for all subsequent washing steps. Cells were
incubated with primary antibodies for 1 h at 37 C. After incuba-
tion, cells were washed for 30 min and incubated with Alexa Fluor
488 and/or Alexa Fluor 546-conjugated secondary antibodies for
1 h at 37 C. Nuclei were labeled with DAPI (0.1 lg/ml in 0.9%
NaCl). Cells were mounted in ProLong Gold antifade reagent
(Molecular Probes) and examined with an Axiovert 100 microscope
(Carl Zeiss, Germany) by using ﬁlters sets that were selective for
each ﬂuorochrome wavelength channel. Images were acquired
with a C2400i integrated charge-coupled device camera (Hamamatsu
Photonics, Shizuoka, Japan) and an Argus 20 image processor
(Hamamatsu). Control experiments with no primary antibodies
showed only faint background staining (supplementary material).
Live-cultured cells grown on collagen-coated aclar coverslips were
examined, and images were acquired by phase contrast micros-
copy with the same microscope and digital system described
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culated by the double-labeling of 24-h cultured cells with both
DAPI (nuclear staining) and desmin (muscle-speciﬁc marker) and
subsequently counting the number of desmin-positive cells in
the total number of cells in the ﬁeld; on average, myoblasts made
up 85% of each culture and ﬁbroblastic cells 15%. For the quantiﬁ-
cation of myoblast fusion, 72-h myogenic cultures were ﬁxed with
4% paraformaldehyde (in PBS) and stained with DAPI and anti-
sarcomeric a-actinin antibody. The number of nuclei per myotube
(fusion index) was recorded in control (untreated) and in treated
cultures. At least 50 microscopic ﬁelds for each culture condition
were used from at least three independent experiments.
2.6. Polyacrylamide gel electrophoresis and immunoblotting
Myogenic cells were quickly washed in ice-cold PBS and 50 ll of
sample buffer (4% sodium dodecyl sulphate – SDS, 20% glycerol,
0.2 M dithioethreitol, 125 mM Tris–HCl, pH 6.8) were added to
the cells and boiled for 5 min. The amount of protein in each
sample was determined according to Bradford [21], using bovine
serum albumin as a standard, and equal amounts of protein
were loaded on the gel. Samples were loaded in 10% SDS–
polyacrylamide gels (SDS–PAGE) and transferred to PVDF
membranes. The proteins immobilized on the membranes were
immediately blocked for 1 h at room temperature with a 5% non-
fat dry milk in Tris buffered saline–Tween 20 solution (0.001%)
(TBS–T). Then, the PVDF membranes were incubated with either
a mouse monoclonal anti-myogenin antibody (dilution 1:200 in
TBS–T), or a mouse monoclonal anti-sarcomeric tropomyosin
(dilution 1:3000 in TBS–T), or a rabbit polyclonal anti-desmin
antibody (dilution 1:3000 in TBS–T). After ﬁve washes in TBS–T
(3 min each), the membranes were incubated with either aFig. 1. a-Cyclodextrin enhances myogenic differentiation. Control myogenic cells were g
of a-cyclodextrin (B) or 2 mM of methyl-b-cyclodextrin (C) for 30 min and grown fo
representative image of each experiment is shown, selected from three independent
represents 50 lm. For the quantiﬁcation of myotube thickness (D), phase contrast image
region containing the larger diameter of each myotube were measured. ⁄ P < 0.05; ANOVperoxidase-conjugated goat anti-rabbit or goat anti-mouse anti-
bodies (dilution 1:7000 in TBS–T), washed again as described
above and the bands were visualized using the ECL plus Western
Blotting Detection System (Amersham). To check sample loading,
another PVDF membrane (containing the same samples in the
same volume used for the other blots) was incubated with a mouse
monoclonal anti-a-tubulin antibody (dilution 1:3000 in TBS–T).
After ﬁve washes in TBS–T (3 min each), the membrane was incu-
bated with a peroxidase-conjugated goat anti-mouse antibody
(dilution 1:7000 in TBS–T) and developed as described above.
Quantiﬁcation of protein bands was performed using the public
domain software ImageJ (http://rsb.info.nih.gov/ij/) with data
obtained from three independent experiments.
2.7. Elisa
The levels of IL-4 in cultured media were determined by
enzyme-linked immunosorbent assay (ELISA) protocol as stan-
dardized by R&D Systems (USA). Conditioned media were collected
from the following conditions: immediately after aCD or MbCD
treatment, or 3 h after treatment, or 24 h after treatment. Samples
were centrifuged and the supernatants used for measurement of
the concentration of IL-4. Brieﬂy, the anti-mouse IL-4 capture
monoclonal antibody (2 lg/ml, R&D Systems, USA) was absorbed
on a polystyrene 96-well plate (Maxisorb, NUNC, Denmark), and
the IL-4 present in the sample was bound to the antibody-coated
wells. The recombinant mouse IL-4 (16–0.125 gg/ml, R&D Sys-
tems, USA) was added to standard wells. The biotinylated anti-
mouse IL-4 detecting mAb (0.1 lg/ml, R&D Systems, USA) was
added to bind the IL-4 captured by the ﬁrst antibody. After wash-
ing, streptavidin–horseradish peroxidase (streptavidin–HRP,
Zymed, USA) was added to the wells to detect the biotinylatedrown for 72 h (A), and other myogenic cells were grown for 24 h, treated with 2 mM
r the next 48 h. Live cells were analyzed under phase contrast microscopy. One
experiments. Arrows point to multinucleated myotubes in each image. Scale bar
s of at least 50 microscopic ﬁelds for each culture condition were acquired and the
A versus control group.
Fig. 3. Expression of myogenin, tropomyosin and desmin is enhanced after aCD treatment. Control myogenic cells (Ct) were grown for 72 h. Other cells were grown for 24 h,
treated with 2 mM of aCD for 30 min and grown for the next 48 h. Cell culture extracts were analyzed in Western blot using antibodies against myogenin, sarcomeric
tropomyosin or desmin (A). Lower Western blot shows a-tubulin reactivity of the same samples, and was used to normalize sample loading. Quantiﬁcation of protein bands
revealed a 40% increase in the levels of myogenin expression (B) and a 20% increase in the levels of tropomyosin and desmin expression (C and D, respectively) in aCD-treated
cells when compared to control cells. ⁄ P < 0.05; ANOVA versus control group.
Fig. 2. a-Cyclodextrin induces the formation of fully striated myotubes. Myogenic cells were grown for 24 h, treated with 2 mM of aCD for 30 min and grown for the next
48 h. Cells were ﬁxed and triple-stained with an anti-sarcomerica-actinin antibody (A), an anti-desmin antibody (B) and the nuclear dye DAPI (C). Note the a-actinin
distribution in Z-lines along sarcomeres (arrow in A) and desmin ﬁlaments distribution throughout the whole sarcoplasm. A merged image is shown in D. Scale bar represents
10 lm.
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genic solution (TMB, Zymed) was added as a substrate, and acolored product formed in proportion to the amount of IL-4 present
in the samples was stopped with HCl 1 N. Absorbance was read
284 A.C.B. Possidonio et al. / Cytokine 55 (2011) 280–287using 450 nm as wavelength. All samples were analyzed in dupli-
cate. Results of cytokine concentration were expressed in ng/ml
and were mean of three different experiments.
3. Results and discussion
3.1. a-Cyclodextrin enhances myogenic differentiation
In this study we examined the effects of a-cyclodextrin (aCD)
during in vitro myogenesis. To investigate the cellular and molecu-
lar mechanisms associated with aCD treatment during skeletal
muscle differentiation, we treated 24-h cultured primary chick
skeletal muscle cells with aCD (2 mM) for 30 min and allowed
the cells to grow in fresh medium for 48 h. aCD clearly enhanced
myogenic differentiation (Fig. 1). The major change in aCD-treated
myogenic cultures was the formation of thicker multinucleated
myotubes, in contrast with the thinner shape of control myotubes
(Fig. 1A and B). The effects of aCD in the formation of multinucle-
ated myotubes were analyzed by the quantiﬁcation of myotube
thickness in each condition (Fig. 1D). Phase contrast images of
myogenic cultures were acquired and the region containing the
larger diameter of each myotube was measured. As previously
shown by our group [14], MbCD also induces the formation of
thicker myotubes as compared to untreated cells (Fig. 1A and C).
As illustrated in Fig. 1D, aCD treatment induced an 30% increase
and MbCD an 60% increase in the thickness of the myotubes
formed, as compared to untreated cultures.
Myogenic differentiation results in the formation of fully stri-
ated myotubes. The presence of well deﬁned striated myoﬁbrils
is an indicator of myogenic differentiation, since the contractile
apparatus must be maintained with almost crystalline order forFig. 4. Conditioned medium from a-cyclodextrin enhances myogenic differentiation. My
or a MbCD-conditioned medium (C), all collected after 3 h of treatment. Live cells were an
One representative image of each experiment is shown, selected from three independen
grown in different culture conditions. Myogenic cultures (with 24 h) were grown in the
cultures were washed with fresh cultured medium and grown for the next 48 h. Other
conditioned media for the next 48 h: collected from 3 h untreated cultures, collected from
aCD treatment, collected after 3 h of MbCD treatment, or collected after 24 h of MbCD tr
and anti-sarcomeric a-actinin antibody. The number of nuclei per myotube (fusion inde
myotubes for each culture condition were scored in at least three independent experimits efﬁcient function. Thus, to analyze the enhancement of muscle
differentiation observed in aCD-treated cultures, myogenic cells
were triple stained with antibodies against sarcomeric a-actinin
and desmin, and with the nuclear dye DAPI (Fig. 2A–D). aCD-
treated myotubes showed a periodic a-actinin staining in Z-lines
along sarcomeres (Fig. 2A) and desmin ﬁlaments distribution
throughout the whole sarcoplasm (Fig. 2B). The nuclei of these
aCD multinucleated cells were well aligned in a longitudinal man-
ner, similar to control myotubes and in contrast with the clustered
nuclei present in MbCD-multinucleated myotubes (Fig. 2C) [14].
These results show that aCD enhances myogenesis by the forma-
tion of mature well-striated myotubes.
We further analyzed the role of aCD in the induction of myo-
genic differentiation by examining the expression of the myogenic
differentiation marker myogenin. The expression of myogenin was
examined after aCD treatment in extracts of cultured myogenic
cells by 10% SDS–PAGE followed by Western blotting (Fig. 3A).
Quantiﬁcation of immunoblots revealed a 40% increase in the lev-
els of myogenin expression in aCD treated-cells when compared to
control cells (Fig. 3B). We also analyzed the expression of two sar-
comeric proteins, tropomyosin and desmin, after aCD treatment
(Fig. 3A). Quantiﬁcation of immunoblots revealed a 20% increase
in the levels of both tropomyosin and desmin expression in aCD
treated-cells when compared to control cells (Fig. 3C and D). These
results show that aCD induces the expression of myogenin, tropo-
myosin and desmin in chick myogenic cells.
The collection of the results shown in Figs. 1–3 shows that aCD
enhances myogenic differentiation by the increase in the thickness
of the myotubes formed and that these myotubes are made by
mature well-striated myoﬁbrils. Thus, we can conclude that aCD
induces muscle hypertrophy, which is deﬁned by the increase inogenic cells (with 24 h) were grown in the presence of a control- (A), or an aCD- (B)
alyzed under phase contrast microscopy. Arrows point to multinucleated myotubes.
t experiments. Scale bar represents 50 lm. (D) Fusion index of chick myogenic cells
presence of aCD or MbCD, both at a ﬁnal concentration of 2 mM. After treatment,
myogenic cultures (with 24 h) were grown in the presence of one of the following
24 h untreated cultures, collected after 3 h of aCD treatment, collected after 24 h of
eatment. Cells were ﬁxed with 4% paraformaldheyde and double-stained with DAPI
x) was analyzed in control untreated cultures (Ct) and in treated cells. At least 50
ents. ⁄ P < 0.01; ANOVA versus control group.
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comeric proteins content.Fig. 6. aCD enhances the levels of IL-4 in the cultured media. IL-4 levels in
conditioned media were measured by ELISA revealing signiﬁcantly higher levels of
IL-4 in conditioned media collected 3 or 24 h after aCD treatment than untreated
cultures. All samples were analyzed in duplicate and results of cytokine concen-
tration were expressed in gg/ml and were mean of three different experiments.
⁄P < 0.01; ANOVA versus control group.3.2. Conditioned medium from a-cyclodextrin enhances myogenic
differentiation
To investigate whether the cellular effects induced by aCD were
caused by soluble factors present in the culture medium, we
decided to analyze the effects of conditioned media collected from
myogenic cultures treated with aCD. Myogenic cells grown in the
presence of aCD-conditioned media (collected after 3 h of treat-
ment) and analyzed by phase contrast microscopy shows a signif-
icant enhancement in muscle differentiation when compared to
untreated cultures (Fig. 4A and B). The enhancement of myogenic
differentiation observed after the treatment of the cells with
aCD-conditioned media was similar to the effects observed with
MbCD-conditioned media, as analyzed by the size of myotubes in
each condition (Fig. 4B and C). These results suggest that the effects
induced by aCD could be caused by soluble factors present in the
culture medium. We have shown recently that myogenic cells
grown with a MbCD-conditioned medium accelerates myogenesis
in a similar way as MbCD does by itself [16]. These results show
that both aCD and MbCD, as well as aCD- and MbCD-conditioned
media, signiﬁcantly enhances myogenesis, as noted by the quanti-
ﬁcation of the fusion index (the number of nuclei per myotube) in
each treatment (Fig. 4D). We also tested whether the soluble fac-
tors present in the culture medium were secreted soon after (3 h
after) or 24 h after aCD treatment. Control cultures (with 24 h)
were grown in the presence of one of the following conditioned
media: collected from a 3 h untreated culture, collected from aFig. 5. The amount of proteins and phospholipids is enhanced in the conditioned media
phospholipids (C) was estimated in the following conditions: minimum essential medium
from 24-h untreated cell cultures (Ct 0 h), growth medium from cultures immediately
growth medium collected after 24 h of aCD treatment (aCD 24 h) or 24 h after MbCD
PS = phosphatidylserine, SM = sphingomyelin, PI = phosphatidylinositol. (D) Quantiﬁcatio
aCD-conditioned media when compared to control untreated-conditioned media. Each
⁄ P < 0.05; ANOVA versus GM group (in B) and versus control group (in A and D).24 h untreated culture, collected after 3 h of aCD treatment, col-
lected after 24 h of aCD treatment, collected after 3 h of MbCD
treatment, or collected after 24 h of MbCD treatment. These data
shows that both aCD-conditioned media (collected after 3 or 24 h
of aCD treatment) induced myogenic differentiation (Fig. 4D), as
analyzed by the fusion index in each treatment. We can conclude
from these experiments that the soluble factors that are present
in the aCD-conditioned media are been continuously released after
aCD induction.after a-cyclodextrin treatment. The total amount of proteins (A), cholesterol (B) and
(MEM), growth medium stock solution (GM; prior to cell feeding), growth medium
after aCD treatment (aCD 0 h) or immediately after MbCD treatment (MbCD 0 h),
treatment (MbCD 24 h). (C) Thin layer chromatography: PC = phosphatidylcholine,
n of phospholipid bands revealed an increase in the levels of phosphatidylinositol in
bar represents the mean and standard error of three independent experiments.
Fig. 7. IL-4 is directly involved in the enhancement of myogenic differentiation induced by aCD. Myogenic cultures (with 24 h) were treated with aCD (2 mM) for 30 min and
then grown in the presence of either a mouse monoclonal antibody against IL-4 (10 lg/ml, anti-IL4) or a recombinant IL-4 molecule (10 gg/ml, IL4) for the next 24 h.
Untreated (control) and treated cells were ﬁxed with 4% paraformaldehyde and triple labeled with antibodies against desmin (green) and sarcomeric a-actinin (red) and the
nuclear dye DAPI (blue). Treatment with the anti-IL4 antibody immediately after aCD exposure inhibited the aCD-induced effects on myotube thickness; while recombinant
IL-4 alone induced the formation of myotubes with similar thickness as the ones found in aCD-treated cultures. Scale bar represents 50 lm.
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after a-cyclodextrin treatment
In order to understand the nature of the molecules released in
the cultured media after aCD treatment, we analyzed the presence
of proteins, cholesterol and phospholipids in aCD-conditioned
media immediately after or 24 h after treatment. First we analyzed
the total amount of proteins present in the conditioned media col-
lected from aCD-treated, MbCD-treated and untreated cultures
(Fig. 5A). We found a signiﬁcant increase in the amount of proteins
present in the conditioned media collected 24 h after aCD treat-
ment, when compared to conditioned media collected from all
other treatments and time points. Next, we analyzed the amount
of cholesterol present in the conditioned media collected from
aCD-treated, MbCD-treated and untreated cultures (Fig. 5B). We
did not ﬁnd a signiﬁcant difference in the amount of cholesterolpresent in aCD-conditioned media when compared to untreated
or MbCD-conditioned media. As expected, the amount of choles-
terol was higher in MbCD-conditioned media (Fig. 5B), since MbCD
is highly efﬁcient in extracting cholesterol from cell membranes
[13,22]. Since aCD has been shown to be the most efﬁcient cyclo-
dextrin in extracting membrane phospholipids [12], we next
explored the nature of the phospholipids present in aCD-
conditioned medium by thin layered chromatography (Fig. 5C).
We detected the presence of phosphatidylcholine, phosphatidyl-
serine, phosphatidylinositol and sphingomyelin, with a slight
increase in the amount of phosphatidylinositol in aCD-conditioned
medium, as compared to MbCD-conditioned medium and control-
conditioned medium (Fig. 5D). We are currently analyzing whether
phosphatidylinositol and other phospholipids are released as
isolated molecules and/or as part of microvesicles after aCD treat-
ment. It is possible to speculate that the release of phospholipids
A.C.B. Possidonio et al. / Cytokine 55 (2011) 280–287 287after aCD treatment induces the vesiculation of the membrane,
which could ultimately lead to membrane breakdown and in this
way could facilitate myoblast fusion.
3.4. aCD induces an increase in the amount of IL-4 in the cultured
media
Since we found a signiﬁcant increase in the amount of proteins
present in the conditionedmedia collected 24 h after aCD treatment
(Fig. 5A), we decided to explore the involvement of key soluble pro-
teins that have been described to enhance myoblast fusion and/or
muscle differentiation. By examining one of these candidates, we
found an increase in the levels of the interleukin IL-4 in conditioned
media collected 3 or 24 h after aCD treatment (Fig. 6). Horsley and
colleagues [5] has shown that IL-4 can act as amyoblast recruitment
factor and therefore couldbe involved in the increase inmyoblast fu-
sion and muscle differentiation observed after aCD treatment. We
also found an increase in the levels of IL-4 in conditionedmedia col-
lected immediately after MbCD treatment (Fig. 6). These data are in
accordance with our previous results showing that MbCD induces
the release of proteins, such as Wnt-3a, to the culture media [16].
3.5. IL-4 is directly involved in the enhancement of myogenic
differentiation observed after aCD treatment
To determine whether the increase in the levels of the interleu-
kin IL-4 found in aCD-conditioned media (Fig. 6) was directly cor-
related with the increase in the myogenic differentiation observed
after aCD treatment (Figs. 1–3), we next examined the effects of a
neutralizing antibody against IL-4 and a recombinant form of the
IL-4 molecule. Myogenic cultures (with 24 h) were treated with
aCD (2 mM) for 30 min and then grown in the presence of either
a mouse monoclonal antibody against IL-4 (10 lg/ml) or a recom-
binant IL-4 molecule (10 gg/ml) for the next 24 h (Fig. 7). Un-
treated and treated cells were ﬁxed with 4% paraformaldehyde
and triple-labeled with antibodies against desmin and sarcomeric
a-actinin and the nuclear dye DAPI. Analysis of the labeled cells
showed that treatment with the anti-IL4 antibody immediately
after aCD exposure inhibited the formation of thicker myotubes.
Interestingly, recombinant IL-4 alone induced the formation of
thicker myotubes, as compared to untreated cultures (Fig. 7). The
collection of these results shows that IL-4 is directly involved in
the enhancement of myotube thickness and myogenic differentia-
tion observed after aCD treatment.
In conclusion, our results show that a-cyclodextrin enhances
myoblast fusion, myotube thickness and myogenic differentiation,
and therefore care should be taken when using it as an analog con-
trol for MbCD treatment in myogenic cells. Further, these data sug-
gest that the interleukin IL-4 is involved in these events and opens
the exciting possibility that IL-4 release might be triggered by
changes in the organization and integrity of the plasma membrane.
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